Advertisement

Hyperparathyroidism in Patients with Chronic Renal Failure Shortens the Action of Vecuronium

  • Atsuki Okuyama
  • Koichi Takita
  • Yukiko Goda
  • Hiroshi Kawahigashi
  • Osamu Kemmotsu
Conference paper

Abstract

The duration of vecuronium in anephric patients is known to have interpatient variability. It was reported that primary hyperparathyroidism attenuated the action of atracurium. The interpatient variability may be in part due to the degree of parathyroid function. We evaluated the effect of secondary hyperparathyroidism on the duration of vecuronium in patients with chronic renal failure.

Keywords

Public Health Renal Function Renal Failure Human Physiology Chronic Renal Failure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Springer Japan 1995

Authors and Affiliations

  • Atsuki Okuyama
    • 1
  • Koichi Takita
    • 1
  • Yukiko Goda
    • 1
  • Hiroshi Kawahigashi
    • 1
  • Osamu Kemmotsu
    • 1
  1. 1.Department of AnesthesiologyHokkaido University School of MedicineKita-ku, Sapporo 060Japan

Personalised recommendations